Concurrent with product research & development, Pegasus Pharmaceuticals Group Inc. ("Pegasus") is also committed to developing optimal clinical applications.  Based on the different characteristics of its products and a solid foundation on scientific research and clinical studies, Pegasus has integrated the latest concepts in western medicine, Chinese medicine, naturopathy, nutritional science and psychology and developed a unique series of standardized but yet individualized therapies, collectively known as the Careseng® Therapies.

NDCR Anti-cancer Therapy:  Based on system biomedicine, NDCR is a novel integral therapy of three-in-one modality: nourishment/protection (organ/tissue protection) and reversal (multidrug resistance reversal), along with attack (radio-chemotherapy).NDCR therapy helps prevent organ/tissue injury from chemotherapy and/or radiotherapy, sensitize tumors to chemotherapeutic drugs, improve the quality of life of patients, and extend their survival rate.  

HS-CSF Therapy: By stimulating stem cell growth and repairing functional cells, this therapy has shown to help patients with chronic diseases such as metabolic disease, degenerative disorder and autoimmune disease.   

Currently these two therapies have been applied in various clinics across the world with more than 15,000 cases. 

"Careseng Cancer Institute Inc." was registered by Pegasus in 2003 to promote Careseng® Therapies. The company is planning to establish 1500 "Careseng Health Clubs" worldwide in the next ten years.

Website: www.careseng.ca